U
MWRX

UBS’s MEDWORTH RX CORP COM STK (DE) MWRX Stock Holding History

UBS’s Portfolio MWRX Stock Details MWRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5K Hold
625
– – ﹤0.01% 9562
2014
Q2 		$5K Hold
625
– – ﹤0.01% 9597
2014
Q1 		$5K Hold
625
– – ﹤0.01% 9626
2013
Q4 		$5K Buy
+625
New +$5.05K ﹤0.01% 9640

Other funds holding MWRX

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS's MWRX Position: Q3 2014 in Review

UBS held its MEDWORTH RX CORP COM STK (DE) (MWRX) position steady in Q3 2014 at 625 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #9562.

UBS first reported a position in MWRX in Q4 2013 and has held it in 4 quarters since. 16 funds tracked by Wall St. Rank hold MWRX as of Q3 2014.

  • UBS held 625 shares of MEDWORTH RX CORP COM STK (DE) worth $5K as of Q3 2014.
  • UBS left its MEDWORTH RX CORP COM STK (DE) share count unchanged in Q3 2014.
  • MEDWORTH RX CORP COM STK (DE) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9562 holding.
  • UBS first reported a position in MEDWORTH RX CORP COM STK (DE) in Q4 2013 and has held it in 4 quarters since.
  • 16 funds tracked by Wall St. Rank held MEDWORTH RX CORP COM STK (DE) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.